Roderick P J, Jones I, Raleigh V S, McGeown M, Mallick N
North West Thames Regional Health Authority, London.
BMJ. 1994 Oct 29;309(6962):1111-4. doi: 10.1136/bmj.309.6962.1111.
To determine the use of renal replacement therapy by ethnic origin and to ascertain the variation in provision of such therapy and to relate this to the distribution of ethnic minority populations.
Analysis of retrospective and cross sectional data from 19 renal units.
All four Thames regional health authorities.
Patients resident in the Thames regions who were accepted as new patients for renal replacement therapy during 1991 and 1992 and the patients who were already undergoing such treatment between December 1992 and April 1993.
Rates of acceptance for and prevalence of renal replacement therapy among white, black, and Asian people.
The average annual acceptance rates per million in 1991-2 were 61 for white people, 175 for black people, and 178 for Asians, and the prevalences per million were 351, 918, and 957 respectively. The relative risks increased with age. A threefold increase in the acceptance rate occurred in people aged under 55 in both the black and Asian populations, suggesting that the higher rates are probably not due to factors related to access alone. Treatment rates varied considerably among districts, reflecting both the distribution of ethnic minority populations and access to services.
Black and Asian people receive and have a greater need for renal replacement therapy, and the need will increase as these populations age. These findings have important implications for the provision of renal services in districts with a high proportion of ethnic minorities and for the management of diabetes mellitus and hypertension, two important causes of end stage renal failure in these populations.
按种族出身确定肾脏替代疗法的使用情况,查明该疗法提供方面的差异,并将其与少数民族人口分布情况联系起来。
对来自19个肾脏治疗单位的回顾性和横断面数据进行分析。
泰晤士河地区的所有四个区域卫生当局。
居住在泰晤士河地区、在1991年和1992年被接纳为肾脏替代疗法新患者的患者,以及在1992年12月至1993年4月期间正在接受此类治疗的患者。
白人、黑人及亚洲人中肾脏替代疗法的接受率和患病率。
1991 - 1992年每百万人口的年均接受率,白人是61,黑人是175,亚洲人是178;每百万人口的患病率分别为351、918和957。相对风险随年龄增加。在55岁以下的黑人和亚洲人群中,接受率增加了两倍,这表明较高的接受率可能并非仅与获得治疗的因素有关。各地区的治疗率差异很大,既反映了少数民族人口的分布情况,也反映了获得服务的情况。
黑人和亚洲人接受肾脏替代疗法且对此有更大需求,随着这些人群年龄增长,需求还会增加。这些发现对于少数民族比例高的地区提供肾脏服务以及对于糖尿病和高血压(这些人群终末期肾衰竭的两个重要病因)的管理具有重要意义。